ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 35 of 137 for:    "idiopathic inflammatory myopathy"

Kinesio Taping Effects Applied With Different Directions and Tensions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02501915
Recruitment Status : Completed
First Posted : July 17, 2015
Last Update Posted : July 21, 2015
Sponsor:
Collaborator:
University of Brasilia
Information provided by (Responsible Party):
Thiago Vilela Lemos, Universidade Estadual de Goiás

Brief Summary:
The Kinesio Taping (KT ) method was developed more than thirty years ago in order to cause sensory effects through the epidermis and dermis, generating a variety of physiological effects in other systems. Clinical effects are well known levels in muscle, neurological system, injuries, inflammation, edema, among other physiological effects are thus largely in the theoretical framework. Objectives: The aim of this study is to evaluate the Electromyographic (EMG), Electroencephalographic (EEG), muscle temperature and flexibility effects with the Rectus Femoral muscle KT application. Methods: This is a pilot study with six subjects in which they were divided into two groups, A and B. Group A received the application of KT from muscle Origin to Insertion and group B Insertion to Origin, with both groups taped the non-dominant limb and the dominant limb was used as control group. The first application was conducted at 0% and the second with 75 to 100% tension. Evaluations were performed before the first application, immediately and 24 hours later. After this last evaluation, was withdrawn taping, evaluated without taping, reapplied 75 to 100 % of rated voltage and in sequence. The sixth last review was conducted 24 hours after this last application. Before every application a specific vibration was performed on the patellar tendon in order to trigger a neurophysiological imbalance rectus femoral.

Condition or disease Intervention/treatment Phase
MYOSITIS Device: Kinesio Taping Phase 1

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Kinesio Taping Effects Applied With Different Directions and Tensions on Electromyography, Electroencephalography, Local Temperature and Muscle Strength
Study Start Date : February 2014
Actual Primary Completion Date : December 2014
Actual Study Completion Date : January 2015


Arm Intervention/treatment
Experimental: Kinesio Taping (GROUP A)
Received the application of KT from muscle Origin to Insertion
Device: Kinesio Taping
Group A received the application of KT from muscle Origin to Insertion and group B Insertion to Origin, with both groups taped the nondominant limb and the dominant limb was used as control group. Diferent tensions will be applied with the tape to see its possible different affect in the outcomes.
Other Name: Kinesio Tex Tape FP (Finger Print)

Experimental: Kinesio Taping (GROUP B)
received the application of KT from muscle Insertion to Origen
Device: Kinesio Taping
Group A received the application of KT from muscle Origin to Insertion and group B Insertion to Origin, with both groups taped the nondominant limb and the dominant limb was used as control group. Diferent tensions will be applied with the tape to see its possible different affect in the outcomes.
Other Name: Kinesio Tex Tape FP (Finger Print)




Primary Outcome Measures :
  1. Muscle Activity [ Time Frame: The outcome will be evaluated 24 hours after the intervention ]
    Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The Eletromiography/ EMG (mV) will be measure during an maximum isometric voluntary contraction.


Secondary Outcome Measures :
  1. Neurologic Activity [ Time Frame: The outcome will be evaluated 24 hours after the intervention ]
    Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The Eletroencephalography - EEG (Hz) will be measure during an maximum isometric voluntary contraction. Will be analyzed 8 channels related with the motor activity located between the frontal and the central lobe.


Other Outcome Measures:
  1. Muscle Stregth [ Time Frame: The outcome will be evaluated 24 hours after the intervention ]
    Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The strength will be measure by a Hand Hold Dynamometer (Kg/F) during an maximum isometric voluntary contraction.

  2. Local Temperture [ Time Frame: The outcome will be evaluated 24 hours after the intervention ]
    Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The temperature will be measure using Thermography (Degrees Celsius) before the KT applications, and 24 hs after staying with the KT applied to the skin.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Individuals who have authorized the evaluation procedure and through the Term Informed Consent;
  • Individuals male and female of any race, duly enrolled in some college course of Universidade Salgado de Oliveira aged between 18-50 years old;
  • Healthy subjects without disorders of locomotion without injury history the last 6 months in the lower limbs.

Exclusion Criteria:

  • They are considered unfit for research individuals who do not meet the requirements listed above ;
  • Individuals who have higher body mass index (BMI ) to 24.99, as the concentrated presence of fat on muscles can limit the effect of bracing;
  • Individuals with musculoskeletal disorders and referring pain. Since there report that the pain and dysfunction of movement restricted range of motion and function muscular18 ;
  • Individuals who possess too much on the thigh in which prevent proper attachment of bracing and the EMG electrode , or who refuse to perform the trichotomy .
  • they show taping allergy ( an allergy test by putting a small bandage on the skin will be held and observed for 24 hours ) ;
  • Patients with any contraindication how physical activity according to the guideline of the American College of Sports Medicine (ACSM , 1995), nerve root involvement, cardiorespiratory conditions and pregnancy .

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02501915


Sponsors and Collaborators
Universidade Estadual de Goiás
University of Brasilia
Investigators
Study Chair: João V Matheus, PHD Universidade de Brasilia

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Thiago Vilela Lemos, Physical Therapy Professor at Universidade Estadual de Goias; Phd Student at Universidade de Brasília, Universidade Estadual de Goiás
ClinicalTrials.gov Identifier: NCT02501915     History of Changes
Other Study ID Numbers: 26582214.4.0000.5289
First Posted: July 17, 2015    Key Record Dates
Last Update Posted: July 21, 2015
Last Verified: July 2015

Keywords provided by Thiago Vilela Lemos, Universidade Estadual de Goiás:
Muscle

Additional relevant MeSH terms:
Myositis
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases